FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042937487> ?p ?o ?g. }

• W2042937487 endingPage "463" @default.
• W2042937487 startingPage "463" @default.
• W2042937487 abstract "Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model Feng-Yun J Huang,1 Te-Wei Lee,2 Chih-Hsien Chang,2 Liang-Cheng Chen,2 Wei-Hsin Hsu,2 Chien-Wen Chang,1 Jem-Mau Lo1 1Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan; 2Institute of Nuclear Energy Research, Longtan, Taiwan Purpose: In this study, the 188Re-labeled PEGylated nanoliposome (188Re-liposome) was prepared and evaluated as a therapeutic agent for glioma.Materials and methods: The reporter cell line, F98luc was prepared via Lentivector expression kit system and used to set up the orthotopic glioma-bearing rat model for non-invasive bioluminescent imaging. The maximum tolerated dose applicable in Fischer344 rats was explored via body weight monitoring of the rats after single intravenous injection of 188Re-liposome with varying dosages before the treatment study. The OLINDA/EXM 1.1 software was utilized for estimating the radiation dosimetry. To assess the therapeutic efficacy, tumor-bearing rats were intravenously administered 188Re-liposome or normal saline followed by monitoring of the tumor growth and animal survival time. In addition, the histopathological examinations of tumors were conducted on the 188Re-liposome-treated rats.Results: By using bioluminescent imaging, the well-established reporter cell line (F98luc) showed a high relationship between cell number and its bioluminescent intensity (R2=0.99) in vitro; furthermore, it could also provide clear tumor imaging for monitoring tumor growth in vivo. The maximum tolerated dose of 188Re-liposome in Fischer344 rats was estimated to be 333 MBq. According to the dosimetry results, higher equivalent doses were observed in spleen and kidneys while very less were in normal brain, red marrow, and thyroid. For therapeutic efficacy study, the progression of tumor growth in terms of tumor volume and/or tumor weight was significantly slower for the 188Re-liposome-treated group than the control group (P<0.05). As a result, the lifespan of glioma-bearing rats treated with 188Re-liposome was prolonged 10.67% compared to the control group.Conclusion: The radiotherapeutic evaluation by dosimetry and survival studies have demonstrated that passive targeting 188Re-liposome via systemic administration can significantly prolong the lifespan of orthotopic glioma-bearing rats while maintaining reasonable systemic radiation safety. Therefore, 188Re-liposome could be a potential therapeutic agent for glioblastoma multiforme treatment. Keywords: 188Re, liposome, radionuclide therapy, bioluminescent imaging, glioma" @default.
• W2042937487 created "2016-06-24" @default.
• W2042937487 creator A5003261770 @default.
• W2042937487 creator A5038656475 @default.
• W2042937487 creator A5046777382 @default.
• W2042937487 creator A5048286805 @default.
• W2042937487 creator A5050178206 @default.
• W2042937487 creator A5055552667 @default.
• W2042937487 creator A5057241756 @default.
• W2042937487 date "2015-01-01" @default.
• W2042937487 modified "2023-10-16" @default.
• W2042937487 title "Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model" @default.
• W2042937487 cites W1513897103 @default.
• W2042937487 cites W1849788055 @default.
• W2042937487 cites W1946923111 @default.
• W2042937487 cites W1968782197 @default.
• W2042937487 cites W1969790128 @default.
• W2042937487 cites W1978894954 @default.
• W2042937487 cites W1985156459 @default.
• W2042937487 cites W1985858988 @default.
• W2042937487 cites W1986718067 @default.
• W2042937487 cites W1989752693 @default.
• W2042937487 cites W1997884315 @default.
• W2042937487 cites W2007719782 @default.
• W2042937487 cites W2010716013 @default.
• W2042937487 cites W2012213756 @default.
• W2042937487 cites W2014821033 @default.
• W2042937487 cites W2020144140 @default.
• W2042937487 cites W2022184843 @default.
• W2042937487 cites W2024808560 @default.
• W2042937487 cites W2026205914 @default.
• W2042937487 cites W2042964201 @default.
• W2042937487 cites W2048834254 @default.
• W2042937487 cites W2057857356 @default.
• W2042937487 cites W2058786507 @default.
• W2042937487 cites W2067742070 @default.
• W2042937487 cites W2069580329 @default.
• W2042937487 cites W2071865941 @default.
• W2042937487 cites W2077846439 @default.
• W2042937487 cites W2082511916 @default.
• W2042937487 cites W2087470910 @default.
• W2042937487 cites W2099431752 @default.
• W2042937487 cites W2105060883 @default.
• W2042937487 cites W2112157234 @default.
• W2042937487 cites W2113452176 @default.
• W2042937487 cites W2113805975 @default.
• W2042937487 cites W2125816970 @default.
• W2042937487 cites W2128356357 @default.
• W2042937487 cites W2133786549 @default.
• W2042937487 cites W2135062838 @default.
• W2042937487 cites W2146629016 @default.
• W2042937487 cites W2148977460 @default.
• W2042937487 cites W2156204466 @default.
• W2042937487 cites W2165871546 @default.
• W2042937487 cites W2169869816 @default.
• W2042937487 cites W2206682348 @default.
• W2042937487 cites W4242403727 @default.
• W2042937487 doi "https://doi.org/10.2147/ijn.s75955" @default.
• W2042937487 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4296959" @default.
• W2042937487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25624760" @default.
• W2042937487 hasPublicationYear "2015" @default.
• W2042937487 type Work @default.
• W2042937487 sameAs 2042937487 @default.
• W2042937487 citedByCount "26" @default.
• W2042937487 countsByYear W20429374872016 @default.
• W2042937487 countsByYear W20429374872017 @default.
• W2042937487 countsByYear W20429374872018 @default.
• W2042937487 countsByYear W20429374872019 @default.
• W2042937487 countsByYear W20429374872020 @default.
• W2042937487 countsByYear W20429374872021 @default.
• W2042937487 countsByYear W20429374872022 @default.
• W2042937487 countsByYear W20429374872023 @default.
• W2042937487 crossrefType "journal-article" @default.
• W2042937487 hasAuthorship W2042937487A5003261770 @default.
• W2042937487 hasAuthorship W2042937487A5038656475 @default.
• W2042937487 hasAuthorship W2042937487A5046777382 @default.
• W2042937487 hasAuthorship W2042937487A5048286805 @default.
• W2042937487 hasAuthorship W2042937487A5050178206 @default.
• W2042937487 hasAuthorship W2042937487A5055552667 @default.
• W2042937487 hasAuthorship W2042937487A5057241756 @default.
• W2042937487 hasBestOaLocation W20429374871 @default.
• W2042937487 hasConcept C150903083 @default.
• W2042937487 hasConcept C185154212 @default.
• W2042937487 hasConcept C185592680 @default.
• W2042937487 hasConcept C207001950 @default.
• W2042937487 hasConcept C2778227246 @default.
• W2042937487 hasConcept C2989005 @default.
• W2042937487 hasConcept C2993559085 @default.
• W2042937487 hasConcept C502942594 @default.
• W2042937487 hasConcept C55493867 @default.
• W2042937487 hasConcept C71924100 @default.
• W2042937487 hasConcept C86803240 @default.
• W2042937487 hasConcept C98274493 @default.
• W2042937487 hasConceptScore W2042937487C150903083 @default.
• W2042937487 hasConceptScore W2042937487C185154212 @default.
• W2042937487 hasConceptScore W2042937487C185592680 @default.
• W2042937487 hasConceptScore W2042937487C207001950 @default.
• W2042937487 hasConceptScore W2042937487C2778227246 @default.

• next